DK0970080T3 - Imino-aza-anthracyclinonderivater til behandling af amyloid degeneration - Google Patents

Imino-aza-anthracyclinonderivater til behandling af amyloid degeneration

Info

Publication number
DK0970080T3
DK0970080T3 DK98901964T DK98901964T DK0970080T3 DK 0970080 T3 DK0970080 T3 DK 0970080T3 DK 98901964 T DK98901964 T DK 98901964T DK 98901964 T DK98901964 T DK 98901964T DK 0970080 T3 DK0970080 T3 DK 0970080T3
Authority
DK
Denmark
Prior art keywords
aza
imino
treatment
anthracyclinone derivatives
amyloid degeneration
Prior art date
Application number
DK98901964T
Other languages
Danish (da)
English (en)
Inventor
Michele Caruso
Daniela Faiardi
Tiziano Bandiera
Jacqueline Lansen
Antonino Suarato
Original Assignee
Pharmacia Italia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Italia Spa filed Critical Pharmacia Italia Spa
Application granted granted Critical
Publication of DK0970080T3 publication Critical patent/DK0970080T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D451/00Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
DK98901964T 1997-01-27 1998-01-09 Imino-aza-anthracyclinonderivater til behandling af amyloid degeneration DK0970080T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9701628.1A GB9701628D0 (en) 1997-01-27 1997-01-27 Imino-aza-anthracyclinone derivatives
PCT/EP1998/000152 WO1998032754A1 (en) 1997-01-27 1998-01-09 Imino-aza-anthracyclinone derivatives for the treatment of amyloidosis

Publications (1)

Publication Number Publication Date
DK0970080T3 true DK0970080T3 (da) 2003-07-21

Family

ID=10806639

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98901964T DK0970080T3 (da) 1997-01-27 1998-01-09 Imino-aza-anthracyclinonderivater til behandling af amyloid degeneration

Country Status (25)

Country Link
US (1) US6194422B1 (pl)
EP (1) EP0970080B1 (pl)
JP (1) JP2001511123A (pl)
KR (1) KR20000070483A (pl)
CN (1) CN1103774C (pl)
AR (1) AR011572A1 (pl)
AT (1) ATE235494T1 (pl)
AU (1) AU745981B2 (pl)
BR (1) BR9815448A (pl)
CA (1) CA2277951C (pl)
DE (1) DE69812599T2 (pl)
DK (1) DK0970080T3 (pl)
EA (1) EA001887B1 (pl)
ES (1) ES2195313T3 (pl)
GB (1) GB9701628D0 (pl)
HU (1) HUP0001222A3 (pl)
IL (1) IL130831A (pl)
NO (1) NO313198B1 (pl)
NZ (1) NZ337221A (pl)
PL (1) PL190304B1 (pl)
PT (1) PT970080E (pl)
TW (1) TW519544B (pl)
UA (1) UA57063C2 (pl)
WO (1) WO1998032754A1 (pl)
ZA (1) ZA98611B (pl)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9902938D0 (en) * 1999-02-10 1999-03-31 Novartis Ag Organic compounds
GB9911804D0 (en) * 1999-05-20 1999-07-21 Merck Sharp & Dohme Therapeutic combination
US7053191B2 (en) * 2003-05-21 2006-05-30 Solux Corporation Method of preparing 4-R-substituted 4-demethoxydaunorubicin
US8357785B2 (en) * 2008-01-08 2013-01-22 Solux Corporation Method of aralkylation of 4′-hydroxyl group of anthracylins
WO2012119079A1 (en) * 2011-03-03 2012-09-07 Indiana University Research And Technology Corporation uPAR-uPA INTERACTION INHIBITORS AND METHODS FOR TREATING CANCER
US8846882B2 (en) 2011-04-29 2014-09-30 Synbias Pharma Ag Method of producing 4-demethoxydaunorubicin

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2258652A (en) * 1991-08-15 1993-02-17 Merck Sharp & Dohme Pharmaceutically useful azabicyclic oxime ethers
GB9416007D0 (en) 1994-08-08 1994-09-28 Erba Carlo Spa Anthracyclinone derivatives
GB9418260D0 (en) * 1994-09-09 1994-10-26 Erba Carlo Spa Anthracycline derivatives
GB9516349D0 (en) * 1995-08-09 1995-10-11 Pharmacia Spa Aza-anthracyclinone derivatives

Also Published As

Publication number Publication date
JP2001511123A (ja) 2001-08-07
EA001887B1 (ru) 2001-10-22
DE69812599D1 (de) 2003-04-30
GB9701628D0 (en) 1997-03-19
EP0970080A1 (en) 2000-01-12
NO993549D0 (no) 1999-07-20
TW519544B (en) 2003-02-01
WO1998032754A1 (en) 1998-07-30
IL130831A0 (en) 2001-01-28
DE69812599T2 (de) 2004-01-08
KR20000070483A (ko) 2000-11-25
NZ337221A (en) 2001-01-26
ZA98611B (en) 1998-08-17
NO313198B1 (no) 2002-08-26
NO993549L (no) 1999-09-21
PT970080E (pt) 2003-07-31
IL130831A (en) 2005-08-31
EA199900684A1 (ru) 2000-04-24
CN1244866A (zh) 2000-02-16
AR011572A1 (es) 2000-08-30
CN1103774C (zh) 2003-03-26
PL190304B1 (pl) 2005-11-30
EP0970080B1 (en) 2003-03-26
PL334803A1 (en) 2000-03-13
UA57063C2 (uk) 2003-06-16
AU745981B2 (en) 2002-04-11
CA2277951C (en) 2006-06-06
AU5863398A (en) 1998-08-18
ATE235494T1 (de) 2003-04-15
BR9815448A (pt) 2001-10-16
CA2277951A1 (en) 1998-07-30
HUP0001222A2 (hu) 2000-10-28
US6194422B1 (en) 2001-02-27
ES2195313T3 (es) 2003-12-01
HUP0001222A3 (en) 2001-01-29

Similar Documents

Publication Publication Date Title
DK1147083T3 (da) Arylpiperazinyl-cyclohexylindolderivater til behandling af depression
NO20012160D0 (no) Anordning for behandling av makulös degenerering
DK1144395T3 (da) 2-amino-benzoxazinon-derivater til behandling af fedme
PT977748E (pt) Derivados benzopirano substituidos para o tratamento de inflamacao
DK1343773T3 (da) Thiazolderivater til behandling af PPAR-beslægtede forstyrrelser
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
DK1063990T3 (da) Anvendelse af Biochanin-beriget ekstrakt til behandling af östrogen-associerede lidelser
DK1093370T3 (da) Farmaceutisk præparat til behandling af diabetes
DK0812845T3 (da) Fremgangsmåde til fremstilling af sildenafil
EE200000155A (et) Taksoidide klassi kuuluvate derivaatide valmistamismeetod
DK1150991T3 (da) Præparater til behandling af inflammatoriske reaktioner
PT869121E (pt) Derivados de propanolamina hipolipidemicos
DK1041985T3 (da) Kombination af benzocycloheptapyridinforbindelser og antineoplastiske lægemidler til behandling af profilerative sygdomme
DK1028960T3 (da) Fremgangsmåde til fremstilling af thiazolidinedion
DK0864564T3 (da) Særlig fremgangsmåde til fremstillingen af alfa-bromlactamderivater
DK0970080T3 (da) Imino-aza-anthracyclinonderivater til behandling af amyloid degeneration
DK0946514T3 (da) Fremgangsmåde til fremstilling af n-substituerede 3-hydroxypyrazoler
DK1121356T3 (da) 3-tetrahydropyridin-4-yl-indoler til behandling af psykotiske lidelser
FI102647B (fi) Ohjelmoitava vahvistin
NO20003481D0 (no) FremgangsmÕte for behandling av COPD
DK1200447T3 (da) Oxazinocarbazoler til behandling af CNS-sygdomme
DK1012152T3 (da) Fremgangsmåde til fremstilling af oxazaphosphorin-2-aminer
DK0855379T3 (da) Fremgangsmåde til fremstilling af benzophenonderivater
IS5481A (is) Samsett meðferð til meðhöndlunar á alnæmi
DK1158950T3 (da) antikonvulsive derivater til behandling af essentiel tremor